Brenda Barnes

… continuing to operate as a going concern) remains in place. With corporate oversight questions looming since CEO Brenda Barnes stepped down for health reasons in August, Sara Lee has been in limbo, garnering interest from financial and strategic …

… product firm to be a takeover target, particularly given that its corporate oversight remains in question after CEO Brenda Barnes stepped down for health reasons in August, making it vulnerable to bids. With its shares now trading at around 9 …

… product firm to be a takeover target, particularly given that its corporate oversight remains in question after CEO Brenda Barnes stepped down for health reasons in August, making it vulnerable to bids. With its shares now trading at around 9 …

… both strategic and financial suitors, particularly given that its corporate oversight remains in question after CEO Brenda Barnes stepped down for health reasons in August, making the firm vulnerable to bids. Beyond looking to sell the combined …

… divestiture of the lower-margin bakery segment, and corporate oversight questions linger following the departure of CEO Brenda Barnes for health reasons in August. Although the divestiture of the bakery business may actually deter private equity firms …

… range) and debt/EBITDA of less than 2 times. In addition, the firm has been in limbo since the departure of CEO Brenda Barnes for health reasons in August, and KKR may consider this a window of opportunity. We would expect a private equity …

On Monday, Sara Lee SLE announced that Brenda Barnes is stepping down from the CEO position, after suffering from a stroke in May. CFO Marcel Smits will continue to serve as interim …

… consistent sales and operating profit growth, which has been the firm's Achilles' heel over the past several years. CEO Brenda Barnes is on medical leave, recovering from a stroke. We expect to garner additional details on her condition when Sara …